The trademark IOME Bio was filed by IOME BIO, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on March 16, 2021, and received two oppositions.
Opposition Proceedings
There are two Oppositions claimed against trademark.
The first opposition filed on June 14, 2021 by Bracco Suisse S.A. on Likelihood of confusion. the opponent was represented by CON LOR S.P.A. and its proceedings were handled in English The second opposition filed on June 9, 2021 by LABORATOIRE NUTERGIA on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. and its proceedings were handled in French
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products
Medicines
Chemical preparations for medical purposes
Biological preparations for medical purposes
Therapeutic drugs and agents
Vaccines
Pharmaceuticals in the nature of cultures of microorganisms for medical use
Preparations of microorganisms for medical purposes
Pharmaceutical preparations and substances for use in oncology and immuno-oncology
Pharmaceutical preparations for suppressing tumors
Compounds for treating cancer
Pharmaceutical preparations for the treatment of cancer based on immuno-modulation
Pharmaceutical preparations for the treatment of metabolic diseases and disorders, inflammatory diseases and disorders, immune system related diseases and disorders
Monoclonal antibodies for medical purposes
Microbiome therapeutics for the treatment of metabolic diseases and disorders, inflammatory diseases and disorders, immune system related diseases and disorders
Pharmaceutical preparations for repairing the intestinal microbiome
Enzymes and microbiome modulators for medical purposes
None of the aforesaid being in connection with medical imaging goods, vitamins, nutritional supplements, food supplements and probiotic supplements.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and development related thereto
Scientific research
Laboratory research
Scientific research for medical purposes in the field of cancerous diseases, metabolic diseases, immune system related diseases, inflammatory diseases, microbiome metabolism, nutraceuticals, monoclonal antibodies
Medical research laboratory services in the field of oncology and immuno-oncology
Research and development services in the field of immunology
Pharmaceutical drug development services
Clinical trials
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Pharmaceutical product evaluation
Conducting early evaluations in the field of new pharmaceuticals
Consultancy relating to research and development in the field of therapeutics
Design and development of testing and analysis methods
Development and test of chemical and biological production methods
None of the aforesaid being in connection with medical imaging goods and services, nutrition advice.